930.3500 -0.30 (-0.03%)
NSE Oct 09, 2025 13:05 PM
Volume: 26,407
 

930.35
-0.03%
BOB Capital Markets Ltd.
Q4 revenue growth at 11% YoY led by broad-based domestic uptick and 17% growth in the US; ROW declined 19% YoY
Alembic Pharmaceuticals Ltd. has lost -25.38% in the last 1 Year
More from Alembic Pharmaceuticals Ltd.
Recommended